|
TMEM136 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.68850000000465E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.041640E-02 |
| Normal-vs-Stage2 |
2.098200E-02 |
| Normal-vs-Stage3 |
1.682190E-03 |
| Normal-vs-Stage4 |
2.300100E-02 |
| Stage1-vs-Stage2 |
1.431190E-01 |
| Stage1-vs-Stage3 |
6.940100E-02 |
| Stage1-vs-Stage4 |
1.165560E-01 |
| Stage2-vs-Stage3 |
7.029200E-01 |
| Stage2-vs-Stage4 |
8.688200E-01 |
| Stage3-vs-Stage4 |
5.513200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.220600E-04 |
| Normal-vs-AfricanAmerican |
5.246800E-04 |
| Normal-vs-Asian |
2.505000E-01 |
| Caucasian-vs-AfricanAmerican |
3.276400E-01 |
| Caucasian-vs-Asian |
4.818200E-01 |
| AfricanAmerican-vs-Asian |
7.719200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.720400E-02 |
| Normal-vs-Female |
4.56039994656265E-09 |
| Male-vs-Female |
2.4577000001802E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.010200E-04 |
| Normal-vs-Extreme_Weight |
2.299600E-02 |
| Normal-vs-Obese |
2.164100E-04 |
| Normal-vs-Extreme_Obese |
2.844800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.878280E-02 |
| Normal_Weight-vs-Obese |
6.021000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.717000E-01 |
| Extreme_Weight-vs-Obese |
1.623680E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.845200E-01 |
| Obese-vs-Extreme_Obese |
5.923400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.661300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.955000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.317460E-03 |
| Normal-vs-Age(81-100Yrs) |
3.004000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.854200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.111900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.336300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.764400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.240100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.464420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.299800E-02 |
| Normal-VS-Type2 PRCC |
1.141450E-03 |
| Normal-VS-KIRP CIMP |
5.821600E-04 |
| Normal-VS-Unclassified PRCC |
4.606200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.450100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.961270E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.312040E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.80940000000085E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.047600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.192930E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.777400E-03 |
| Normal-vs-N1 |
2.076000E-03 |
| Normal-vs-N2 |
7.522600E-03 |
| N0-vs-N1 |
1.701200E-01 |
| N0-vs-N2 |
6.016600E-01 |
| N1-vs-N2 |
8.695400E-01 |
|
|
